Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Study of New Formulation Ophthalmic Cysteamine Hydrochloride for Corneal Cystine Accumulation in Patients With Cystinosis

NCT00010426 is registered in ClinicalTrials.gov with FDA Office of Orphan Products Development as lead sponsor.

NCT NCT00010426
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00010426 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Study of New Formulation Ophthalmic Cysteamine Hydrochloride for Corneal Cystine Accumulation in Patients With Cystinosis
Lead sponsor
FDA Office of Orphan Products Development
Phase
Not applicable
Overall status
Completed
Start date
December 31, 1999
Completion date
February 28, 2001
Enrollment
30
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

cystinosis